The biotech industry has exhibited resilience and versatility, particularly throughout the pandemic, thanks to its advanced innovations and relentless pursuit of mitigating the hazardous virus. Its strong position is further bolstered by a consistent demand that secures the industry's stability in the foreseeable future.
Against this backdrop, investors might want to direct their attention to quality biotech stocks Organogenesis Holdings Inc. (ORGO), Theratechnologies Inc. (THTX), and Vertex Pharmaceuticals Incorporated (VRTX) to elevate and invigorate their portfolios.
